Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study

• Published in: Journal of diabetes and its complications 2023-01, Vol.37 (1), p.108379-108379, Article 108379
• Main Authors: Kania, Michał, Suduł, Paulina, Mazur, Konrad, Chaykivska, Zlata, Fiema, Mateusz, Kopka, Marianna, Kostrzycka, Małgorzata, Wilk, Magdalena, Hohendorff, Jerzy, Kieć-Wilk, Beata, Klupa, Tomasz, Witek, Przemysław, Katra, Barbara, Malecki, Maciej T.
• Format: Article
• Language: English
• Subjects: Adult; Ambulatory Care; Body mass index; Clinical outcomes; Cohort analysis; Cohort Studies; COVID-19; COVID-19 - epidemiology; COVID-19 - therapy; Diabetes; Diabetes Mellitus, Type 1 - epidemiology; Diabetes Mellitus, Type 1 - therapy; Diabetic retinopathy; Disease; Glycated Hemoglobin; Glycemic control; Health care; Hospitals; Humans; Insulin; Medical records; Mortality; Outpatient care; Pandemics; Patients; Retrospective Studies; Telemedicine; Treatment Outcome; Type 1 diabetes
• ISSN: 1056-8727; 1873-460X
• DOI: 10.1016/j.jdiacomp.2022.108379

COVID-19 has brought many challenges for providing quality healthcare for type 1 diabetes (T1DM). We evaluated the impact of the COVID-19 pandemic on the medical care, glycemic control, and selected outcomes in T1DM patients. We retrospectively analyzed medical records from 357 T1DM adults enrolled in the Program of Comprehensive Outpatient Specialist Care at the University Hospital in Krakow, and assessed differences in patient data from before the COVID-19 period (March 2019–February 2020) and after it started COVID-19 (March 2020–February 2021). The median HbA1c levels and the percentage of patients within the HbA1c target of